EP2363414
Setbeind breyting á FVIII
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
14.11.2005EP published:
18.5.2022EP application number:
11153300.6
EP translation filed:
5.7.2022Grant published:
15.8.2022EPO information:
European Patent Register
Max expiry date:
13.11.2025Expiry date:
13.11.2024
Title in English:
Site-directed modification of FVIIILanguage of the patent:
English
Timeline
Today
14.11.2005EP application
18.5.2022EP Publication
5.7.2022Translation submitted
15.8.2022Registration published
13.11.2024Expires
Owner
Name:
Bayer HealthCare LLCAddress:
100 Bayer Boulevard P.O. Box 915, Whippany, NJ 07981-0915, US
Inventor
Name:
Pan, Clark Q.Address:
Sudbury, MA 01776, US
Name:
Murphy, John E.Address:
Berkeley, California 94707, US
Name:
Mei, BaisongAddress:
Waban, MA 02468-2027, US
Name:
Strauss, Jonathan S.Address:
Walnut Creek, California 94597, US
Name:
Tjandra, HendriAddress:
Union City California 94587-5503, US
Name:
Chen, JianminAddress:
Concord, California 94518, US
Name:
Barnett, ThomasAddress:
Willsborough, NJ 08844, US
Name:
Tang, LiangAddress:
Richmond, California 94806, US
Name:
Wamg, DeqianAddress:
Concord, California 94521, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
627277 PDate:
12.11.2004Country:
US
Classification
Categories:
C07K 14/755, A61K 38/00, A61K 47/48, C07K 17/08
Annual fees
Number
Paid
Expires
Payer
Number: 18
Paid: 27.10.2022
Expires: 13.11.2023
Payer: Árnason Faktor ehf.
Number: 19
Paid: 7.11.2023
Expires: 13.11.2024
Payer: Árnason Faktor ehf.